Picture of Manhattan Scientifics logo

MHTX Manhattan Scientifics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Manhattan Scientifics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1.55-8.33-1.224.31-3.64
Depreciation
Non-Cash Items-3.826.890.564-4.963.05
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.6290.1440.340.260.168
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Cash from Operating Activities-0.791-0.682-0.316-0.388-0.421
Capital Expenditures-0.0080-0.0040
Purchase of Fixed Assets
Other Investing Cash Flow Items0.50.340.4840.3
Sale of Fixed Assets
Sale/Maturity of Investment
Cash from Investing Activities-0.0080.50.340.480.3
Financing Cash Flow Items00
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities000.1500
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-0.799-0.1820.1740.092-0.121

Or unlock with your email

Or unlock with your email